Physician profile
Lee E Shoop
NPI 1023143146
$893.44
in general payments reported to CMS, 2019-2025
15 companies · $202 in 2025
The $202 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $46.18 · 2023: $340 · 2024: $306 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $155.92 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.12 | 2023-2024 | Xifaxan, Trulance |
| Abbvie INC. | $90.05 | 2024 | |
| Exact Sciences Corporation | $87.17 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Daiichi Sankyo INC. | $81.95 | 2024-2025 | Injectafer |
| Astrazeneca Pharmaceuticals Lp | $67.28 | 2022-2024 | Farxiga |
| Merck Sharp & Dohme LLC | $63.16 | 2022-2024 | Gardasil 9, Capvaxive, Gardasil |
| Glaxosmithkline, LLC. | $45.69 | 2022-2025 | Nucala, Trelegy Ellipta |
| Gilead Sciences, INC. | $43.11 | 2023-2024 | |
| Abbott Laboratories | $37.86 | 2023 | Freestyle Libre 2 |
| Mylan Specialty L.P. | $36.92 | 2023-2024 | Yupelri |
| Baxter Healthcare | $30.32 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Dexcom, INC. | $26.25 | 2025 | Dexcom G6 Transmitter |
| Scilex Pharmaceuticals INC. | $16.92 | 2023 | Ztlido |
| Organon LLC | $16.72 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Shoop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.